1 Schwartz JS,Song P,Blitzer A.Spasmodic dysphonia[M].In:Cooper G,Eds.Therapeutic uses of Botulinum toxin.to-towa.NJ:Humana Press inc,2007.110～112.

2 Schweinfurth JM,Billante M,Courey MS.Risk factors and demographics in patients with spasmodic dysphonia[J].La-ryngoscope,2002,112:220.

3 Tisch SHD,Brake NM,Law M,et al.Spasmodic dysphonic:clinical features and effects of botulinum toxin therapy in 169 patients-an Australian experience[J].Journal of Clinical Neuroscience,2003,10:434.

4王丽萍,张玉富,张澍,等.痉挛性发音障碍的喉功能特点[J].听力学及言语疾病杂志,2001,9:199.

5徐文,韩德民,侯丽珍,等.痉挛性发音障碍诊断及治疗的研究[J].中华耳鼻咽喉头颈外科杂志,2005,40:253.

6 Cannito MP.Emotional considerations in spasmodic dysphoni-a:psychometiric quantification[J].Elsevier Science Publish-ing Co,Inc,1991,24:313.

7 Ginsberg BI,Wallack JJ,Srain JJ,et al.Defining the psychi-atric role in spastic dysphonia[J].General Hospital Psychia-try,1988,10:132.

8 Dedo HH,Behlau MB.Recurrent laryngeal nerve section for spastic dysphonia:5-to 14-yeaf prelininary results in the first 300patients[J].Ann otol Rhinol Laryngol,1991,100:274.

9 Blitzer A.Spasmodic dysphonia and botulium toxin:experi-ence from the largest treatment series[J].Eur J Neurol,2010,17:28.

10 Langeveld TP,Drost HA.Unilateral versus bilateral botuli-num toxin injections in adductor spasmodic dysphonia[J].Ann Orol Rhinlo Laryngol,1998,107:280.

11 Kiese-Himmel C.Psychological factors in spasmodic dys-phonia[J].Laryngorhinotologie,1996,75:397.

12 Aronson AE,McCaffrey TV,Litchey WJ,et al.Botulinum toxin injection for adductor spasmodic dysphonia:patient self-rating of voice and phonatory effort after three successive injections[J].Laryngoscope,1993,103:683.

13 Blitzer A,Brin MF,Stewart CF.Botulinum toxin manage-ment of spasmodic dysphonia(laryngeal dystonia):a 12-year experience in more than 900patients[J].Laryngoscope,1998,108:1 435.

14 Benninger MS,Garder G,Grywalski C.Outcomes of botuli-num toxin treatment for patients with spasmodic dysphonia[J].Arch Otolaryngol Head Neck Surg,2001,127:1 083.

15 Ludlow CL.Spasmodic dysphonia:a laryngeal control disor-der specific to speech[J].J Neurosci,2011,31:793.

16杨式麟,何平,吕素清.痉挛性发音障碍与声带麻痹的关系[J].中华耳鼻咽喉科杂志,1998,33:328.

17 Koufman JA,Rees CJ,Halum SL,et al.Treatment of ad-ductor-type spasmodic dysphonia by surgical myectomy:a preliminary report[J].Ann Otol Rhinol Laryngol,2006,115:97.

18 Willinger U,Volk-Kernstock S,Aschauer HN.Marked depression and anxiety in patients with functional dysphonia[J].Psychiatry Res,2005,134:85.

19 Ludlow CL.Spasmodic dysphonia:a laryngeal control disor-der specific to speech[J].J Neurosci,2011,31:793.

20 Blitzer A,Brin MF,Fahn S,et al.Clinical and laboratory characteristics of focal laryngeal dystonia:a study of 110ca-ses[J].Laryngoscope,1988,98:636.

21 Remacle M,Plouin-Gaudon I,Lawson G,et al.Bipolar radio-frequency-induced thermotherapy(rfitt)for the treatment of spasmodic dysphonia.A report of three cases[J].Eur Arch Otorhinolarynbgol,2005,262:871.

22 Tucker HM.Laryngral frameword surgery in the manage-ment of spasmodic dysphonia.Preliminary report[J].Ann Otol Rhinol Laryngol,1989,98:52.

23 Reeuwijk A,van Schie PE,Becher JG,et al.Effects of bot-ulinum toxin type A on upper limb function in children with cerebral palsy:a systematic review[J].Chin Rehabil,2006,20:375.

24 Blitzer A,Brin MF,Fahn S,et al.Clinical and laboratory characteristics of focal laryngeal dystonia:a study of 110ca-ses[J].Laryngoscope,1988,98:636.

25 Blitzer A,Sulica L.Botulinum toxin:basic science and clini-cal uses in otolaryngology[J].Laryngoscope,2001,111:218.

26 Hillel AD,Maronian NC,Waugh PF,et al.Treatment of the interarytenoid muscle with botulinum toxin for laryngeal dystonia[J].Ann Otol Rhinol Laryngol,2004,113:341.

27 Cannito MP,Kahane JC,Chorna L.Vocal aging and adduc-tor spasmodic dysphonia:response to botulinum toxin injec-tion[J].Clinicalinterventions in Aging,2008,3:131.

28 Zwirner P,Murry T,Woodson GE.Perceptual acoustic rela-tionships in spasmodic dysphonia[J].J of Voice.1993,7:165.

29 Cannito MP,Woodson GE,Murry T,et al.Perceptral ana-lyses of spasmodic dysphonia before and after treatment[J].Arch Otolaryngol Head Neck Surg,2004,130:1 393.

30 Galardi G,Guerriero R,Amadio S,et al.Sporadic failure of botulinum toxin treatment in usually responsive patients with adductor spasmodic dysphonia[J].Neurol Sci,2001,22:303.